Inactive Instrument

News Opko Health Inc. TEL AVIV STOCK EXCHANGE

Equities

US68375N1037

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M	05-07	MT
OPKO Health: Q1 Earnings Snapshot	05-07	AQ
Transcript : OPKO Health, Inc., Q1 2024 Earnings Call, May 07, 2024	05-07
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results	05-07	AQ
OPKO Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024	05-06	AQ
OPKO Health : Immediate Report	05-04	PU
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024	05-03	AQ
InvestorBrandMedia: Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc. (NYSEAMERICAN: ATNM) Amidst Groundbreaking Cancer Therapy Innovations	04-01	AQ
Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets	03-28	MT
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome	03-20	AQ
Entera Bio Announces Robust Pharmacokinetic Data for First-In-Class Oral Glp-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome	03-20	CI
OPKO Health : Immediate Report	03-15	PU
Opko Health Insider Bought Shares Worth $444,300, According to a Recent SEC Filing	03-14	MT
Opko Health Insider Bought Shares Worth $463,750, According to a Recent SEC Filing	03-13	MT
Opko Health Insider Bought Shares Worth $559,380, According to a Recent SEC Filing	03-12	MT
OPKO Health - AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV	03-06	AQ
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV	03-05	AQ
OPKO Health : Immediate Report	03-02	PU
OPKO Health : Report of Periodic or Interim Report	03-02	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Opko Health Inc. TEL AVIV STOCK EXCHANGE

Equities

US68375N1037

Summary

Filters